This study compound was initially reported by Hoffman-La Roche in 2009. It’s certainly one of many benzodiazepines during the imidazobenzodiazepine subgroup thought to offer nootropic Positive aspects. This drug was invented by Schlesinger Walter and marketed from the early 80s. It was marketed as becoming “significantly less harmful” than chlordiazepoxide https://campbellj666hbt8.qodsblog.com/profile